CT83 Antibodies

AND CT83 ELISA kits, CT83 Proteins

Many biological assays use antibodies to detect CT83, such as Western Blot (WB), ELISA, Flow Cytometry, Immunocytochemistry (IHC). These antibodies can be polyclonal or monoclonal, and react with CT83 in Human, Mouse, Rat, and many other animal samples. Boster Bio use mainly mouse and rabbit to develop CT83 antibodies...

We validate the specificity of these antibodies to CT83 by testing them on tissues known to express CT83 positively and negatively. Browse below to find the CT83 antibody that suites your experiment. We have 2 of these antibodies and many publications and validation images.

If you cannot find antibodies that fit your needs, contact us for making custom antibodies. We have a full suite of custom antibody services covering from research to diagnostic and therapeutic applications.

Previous: Septin9 Next: NRK

CT83 Infographic by Boster Bio

All CT83 Products

Filter by Application:

Product

Figures

Specificity

Applications

Price

Anti-KKLC1 CT83 Antibody

Western blot analysis of lysates from K562 cells, primary antibody was diluted at 1:1000, 4°C over night

Human

ELISA, WB

$380
Cat # A15702
100ul

KK LC 1 (CT83) (NM_001017978) Human Over-expression Lysate

Human

$628
Cat # LS203413
20 µg, 100 µg

CT83 Overview

Facts about Kita-kyushu lung cancer antigen 1.

CT83 3D structure. Source: alphafold

Kita-kyushu lung cancer antigen 1 (CT83)

Gene Information

Human
Gene Name:	CT83
Uniprot:	Q5H943
Entrez:	203413

Family

Belongs to:

No superfamily

Alternative Names

Kita-kyushu lung cancer antigen 1

Molecular Weight

Mass (kDA):
12.784 kDA

Genomic Context


Human

Location:	Xq23
Sequence:	X; NC_000023.11 (116461686..116462976, complement)

Subcellular Localizations

Cell membrane; Single-pass type II membrane protein.

PTMs

Glycoprotein

For details, visit:
bosterbio.com/bosterbio-gene-info-cards/CT83

References

PMID: 16651449 by Fukuyama T., et al. Identification of a new cancer/germline gene, KK-LC-1, encoding an antigen recognized by autologous CTL induced on human lung adenocarcinoma.